Compared with benign and normal ovarian tissues, PAD4 is overexpressed in most OC subtypes (e.g., serous cystadenocarcinoma, myxoid cystadenocarcinoma, clear cell carcinoma, and germ cell tumors) and is associated with the pathological grade of ovarian cancer [28,29,235]. This evidence concerns the gene PADI4 and ovarian cancer.